A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice

AIMS: The new cyclooxygenase-2 (COX-2) selective inhibitors, celecoxib (Celebrex®) and rofecoxib (Vioxx®), have been widely prescribed since their launch. No reviews currently appear in the literature of prescribing patterns in Australia. This paper describes a self-audit of the clinical use of sele...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cutts, Christopher, LaCaze, Adam, Tett, Susan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2002
Konular:
Pharmacovigilance
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874451/
https://ncbi.nlm.nih.gov/pubmed/12445032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2002.01666.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller